ARCHIVES

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

January 7, 1983

DRCCA Board Approves Concepts Of Four New Antismoking Projects

May 20, 1983

Breast Cancer Survivors Who Take Aspirin Have 50% Reduced Risk Of Metastasis

February 26, 2010

Data Falsification Charge To Be Aired

June 27, 1980

Longer Chemo Regimen Offers Better DFS For Premenopausal Breast Cancer

January 31, 2003

ProPAC Calls For Adjustments In For Tobacco Advertising Ban

July 25, 1986